loading
Schlusskurs vom Vortag:
$5.54
Offen:
$5.65
24-Stunden-Volumen:
29,181
Relative Volume:
0.49
Marktkapitalisierung:
$199.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.50M
KGV:
-7.1948
EPS:
-0.77
Netto-Cashflow:
$-30.10M
1W Leistung:
+0.18%
1M Leistung:
-5.30%
6M Leistung:
+38.33%
1J Leistung:
+78.71%
1-Tages-Spanne:
Value
$5.49
$5.90
1-Wochen-Bereich:
Value
$5.33
$5.90
52-Wochen-Spanne:
Value
$2.6801
$7.19

Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile

Name
Firmenname
Eupraxia Pharmaceuticals Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
33
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
EPRX's Discussions on Twitter

Vergleichen Sie EPRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EPRX
Eupraxia Pharmaceuticals Inc
5.54 280.30M 0 -25.50M -30.10M -0.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.75 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.88 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
435.38 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
820.29 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
181.34 40.44B 447.02M -1.18B -868.57M -6.1812

Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-24 Eingeleitet Cantor Fitzgerald Overweight
2025-06-26 Eingeleitet H.C. Wainwright Buy
2025-06-16 Eingeleitet Canaccord Genuity Speculative Buy
2025-02-21 Eingeleitet Craig Hallum Buy
2024-11-14 Eingeleitet Rodman & Renshaw Buy

Eupraxia Pharmaceuticals Inc Aktie (EPRX) Neueste Nachrichten

pulisher
02:19 AM

Is Eupraxia Pharmaceuticals Inc. stock ready for a breakoutMarket Movement Recap & AI Forecasted Entry and Exit Points - newser.com

02:19 AM
pulisher
01:16 AM

Volatility clustering patterns for Eupraxia Pharmaceuticals Inc.2025 Market Overview & Comprehensive Market Scan Insights - newser.com

01:16 AM
pulisher
01:02 AM

Using data filters to optimize entry into Eupraxia Pharmaceuticals Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com

01:02 AM
pulisher
12:06 PM

Eupraxia Pharmaceuticals Inc. stock prediction for this week2025 Volatility Report & Verified Entry Point Signals - newser.com

12:06 PM
pulisher
Nov 02, 2025

(EPRX.WT.A) Stock Analysis and Trading Signals - news.stocktradersdaily.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Eupraxia Pharmaceuticals Inc. stock see insider buyingWeekly Loss Report & Weekly Hot Stock Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Eupraxia Pharmaceuticals Inc. stock reversal real or fakePortfolio Performance Summary & Real-Time Volume Spike Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Eupraxia Pharmaceuticals Inc. stock bottoming outMarket Trend Summary & Technical Confirmation Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Eupraxia Pharmaceuticals Inc. reversing from oversold territoryNew Guidance & High Accuracy Trade Signal Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Regression analysis insights on Eupraxia Pharmaceuticals Inc. performanceJuly 2025 Market Mood & Weekly High Potential Stock Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

(EPRX) Stock Trading Blueprint (EPRX:CA) - news.stocktradersdaily.com

Nov 02, 2025
pulisher
Nov 02, 2025

Eupraxia Pharmaceuticals Inc. stock trend forecastM&A Rumor & Safe Entry Trade Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Eupraxia Pharmaceuticals Inc. stock continue upward trendQuarterly Profit Summary & Low Drawdown Trading Techniques - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Research Analysts Offer Predictions for EPRX FY2025 Earnings - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Strategies to average down on Eupraxia Pharmaceuticals Inc.July 2025 Earnings & Reliable Trade Execution Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Eupraxia Pharmaceuticals Inc. (EPRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 01, 2025
pulisher
Oct 31, 2025

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded to Strong-Buy at Leede Financial - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Eupraxia Pharmaceuticals (EPRX) Expected to Announce Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

(EPRX.WT.A) Optimized Trading Opportunities - news.stocktradersdaily.com

Oct 31, 2025
pulisher
Oct 30, 2025

Eupraxia Pharmaceuticals Inc. (EPRX.TO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Eupraxia Pharmaceuticals Advances EoE Treatment with EP-104GI Trial - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

This analyst loves Eupraxia Pharmaceuticals - Cantech Letter

Oct 30, 2025
pulisher
Oct 30, 2025

(EPRX) Trading Strategy and Analysis (EPRX:CA) - news.stocktradersdaily.com

Oct 30, 2025
pulisher
Oct 29, 2025

Chart based analysis of Eupraxia Pharmaceuticals Inc. trendsWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is Eupraxia Pharmaceuticals Inc. (X43) stock worth buying before Fed action2025 Momentum Check & Expert Verified Movement Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Is Eupraxia Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Analyst Calls & Fast Entry and Exit Trade Plans - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

(EPRX.WT.A) Strategic Equity Report - news.stocktradersdaily.com

Oct 28, 2025

Finanzdaten der Eupraxia Pharmaceuticals Inc-Aktie (EPRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.23
price down icon 0.68%
$92.89
price down icon 0.72%
$28.92
price up icon 0.96%
$104.23
price up icon 0.19%
biotechnology ONC
$312.02
price up icon 0.74%
$182.66
price down icon 3.82%
Kapitalisierung:     |  Volumen (24h):